EIF2AK3 and neoplasm: In particular, since the inhibition of PERK sensitizes cancer stem cells to apoptosis (Fujimoto et al., 2016), an important aspect of these promising therapies could be the inhibition of cancer stem cell proliferation, which is responsible for post-therapy tumor relapse in oncological patients (Li et al., 2008).